Form 4 for AXGN Axogen, Inc.
Accepted 2023-03-20 00:00:00 ET · period of report 2023-03-16 · accession 0000805928-23-000026 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-03-20 | 2023-03-16 | AXGN | Ottinger Bradley | GC, CCO | F - Tax | $8.27 | -2,634 | 22.9K | -10% | -$21.8K |
| DM | 2023-03-20 | 2023-03-16 | AXGN | Ottinger Bradley | GC, CCO | M - OptEx | $0.00 | +8,463 | 23.7K | +56% | $0 |
| DM | 2023-03-20 | 2023-03-16 | AXGN | Ottinger Bradley | GC, CCO | M - OptEx | $0.00 | -8,463 | 5,900 | -59% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-03-16 | F | D | 1,836 | $8.27 | 23,627 | D | — | — | (F3) Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. |
| 2 | Common | Common Stock | 2023-03-16 | M | A | 2,563 | $0.00 | 25,463 | D | — | — | (F1) This reflects the number of restricted stock units that became vested as of March 16, 2023. |
| 3 | Common | Common Stock | 2023-03-16 | F | D | 798 | $8.27 | 22,900 | D | — | — | (F3) Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. |
| 4 | Common | Common Stock | 2023-03-16 | M | A | 5,900 | $0.00 | 23,698 | D | — | — | (F1) This reflects the number of restricted stock units that became vested as of March 16, 2023. (F2) Includes 3,000 shares acquired under the Axogen stock purchase plan in 2022. |
| 5 | Derivative | Restricted Stock Units | 2023-03-16 | M | D | 2,563 | $0.00 | 2,564 | D | — · — to — | 2,563 Common Stock | (F4) Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock. (F6) All shares of Axogen Inc. common stock underlying the restricted stock units will be fully vested on March 16, 2024 (3 years from the grant date) based upon a vesting schedule whereby 33.33% of the aggregate shares vest on March 16, 2022, 33.33% of the aggregate shares vest on March 16, 2023, and 33.34% of the aggregate shares vest on March 16, 2024. Vested shares will be delivered to the reporting person upon the vesting date. |
| 6 | Derivative | Restricted Stock Units | 2023-03-16 | M | D | 5,900 | $0.00 | 5,900 | D | — · — to — | 5,900 Common Stock | (F4) Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock. (F5) All shares of Axogen Inc. common stock underlying the restricted stock units will be fully vested on March 16, 2025 (4 years from the grant date) based upon a vesting schedule whereby 50% of the aggregate shares vest on March 16, 2023, 25% of the aggregate shares vest on March 16, 2024, and 25% of the aggregate shares vest on March 16, 2025. Vested shares will be delivered to the reporting person upon the vesting date. |